Fig. 6: Overview of participant characteristics and assessment details for studies of spinal cord injury in humans.
From: Impact of commonly administered drugs on the progression of spinal cord injury: a systematic review

D only distributional information reported, NR information not reported, A participants recruited in acute phase after injury, C participants recruited in chronic phase after injury, h: hours, d days, m months, w weeks, y: year, yrs: years, A(H) acute phase hospital stay, A(R) acute phase rehabilitation stay, D(R) discharge from rehabilitation, *: Age (mean and standard deviation) reported for low and high dose groups separately; **: 1 y and 2 y reported if possible but not mandatory.